OpenVSafe by OpenVAERS
Search V-safe

64C-58139-30170

3 vaccinations 4 coded responses 17 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
981 / WA
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-08
    Registered in v-safe
  2. 2021-04-08
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-08
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  4. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fever · Chills
    Adult check-in
  5. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-29
    Dose 2 — Pfizer-BioNTech
  10. 2021-04-29
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pollakiuria — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Frequent urination
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-08
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  13. 2021-05-13
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-05-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Ectopic pregnancy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Eptopic pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-10-29
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  19. 2021-11-01
    Call successful
    Not applicable - Accidental Reporting
  20. 2022-01-12
    Dose 3 — Pfizer-BioNTech
  21. 2022-01-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-13
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-01-14
  24. 2022-07-13
    Survey response — 6 months, dose 3
    MedDRA: Pregnancy, Urinary tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: UTI pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-07-13
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  26. 2022-07-14
  27. 2022-07-14
  28. 2022-07-14
  29. 2023-01-12
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Pfizer-BioNTech
22021-04-29Pfizer-BioNTech
32022-01-12Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-10-29 Successful
2021-11-01
 Not applicable - Accidental Reporting
2022-01-13 Unsuccessful
2022-07-13 Unsuccessful

Free text

Release 8 — days 1–6 daily, dose 2

2021-04-30

Systemic reaction (other): Frequent urination

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: Eptopic pregnancy

Release 10 — days 1–6 daily, dose 3

2022-01-13

Systemic reaction (other): Chest pain

Release 12 — 6 months, dose 3

2022-07-13

Symptoms: UTI pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEctopic pregnancy · · ✓
SDPregnancy · · ✓
SDUrinary tract infection · · ✓
SROChest pain · · ✓
SROPollakiuria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…